New anti-cancer drugs studied through funding from one of the largest pharmaceutical companies in the world
(April 9, 2004) GENEVA, N.Y.– Hilda Castillo, a William Smith junior, has been selected to receive a 2004 Pfizer Summer Undergraduate Research Fellowship. This is the first Pfizer fellowship awarded to an HWS student.
Through the grant, Castillo will work this summer at Cornell University with Carol Parish, associate professor of chemistry at Hobart and William Smith, and Nobel laureate Professor Roald Hoffmann of Cornell. Their research will focus on the quantum mechanical behavior and the role of tautomerization in enediyne warhead drugs.
As part of the fellowship, Castillo and Parish will travel to Pfizer's research facility in Groton, Conn., in October to report on the overall progress made in developing new anti-cancer drugs. While there they will meet with other fellowship recipients, as well as Pfizer scientists.
The fellowship is a competitive award offered to undergraduate majors in the areas of chemistry and biology. Grants are given on the basis of academic merit, faculty recommendation, enthusiasm for science and a proposal describing original research.
Castillo, of New York City, is a biochemistry major and education and Spanish double minor. The daughter of Felix and Alex Castillo, she is the recipient of several fellowships and awards, including the American Chemical Society Scholars Program, the Alger Adams Academic Excellence Award, the Drs. Lynn ’20 and James ’51 Rumbold Memorial Scholarship and a 2003 National Science Foundation Summer Research Fellowship. She chaired a session at the 47th American Chemical Society Rochester Section Undergraduate Chemistry Research Symposium, and has presented her research before the National American Chemical Society.
Castillo is a member of the HWS Chemistry Club and American Chemical Society.
# # #